~~<i id='15D05CD65A'><strike id='15D05CD65A'><tt id='15D05CD65A'><pre id='15D05CD65A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

Wikipedia

author：comprehensive 2025-10-01 14:59:38 - browse：16822

The FDA building -- First Opinion coverage from STAT — Adobe

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives.

Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

To cut through that bureaucracy, Pazdur has a trick: “Don’t tell anybody,” he said to laughter at a meeting of the advocacy group Friends of Cancer Research Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Diverse clinical trials: Why aren’t we there yet?

knowledge

leisure time

Wikipedia

AdobeSincecolorectalcancerisontheriseinpeopleyoungerthanage50,nationalguidelineshaverecentlypushedth

WSS

Creating egg and sperm cells from stem cells raises ethical issues

Pig kidney works a record two months in donated body

Asbestos, a deadly carcinogen, banned by EPA

Will the IRA bring competition to the biologics market?

How housing is health care on Long Island

Popular nasal decongestant doesn't actually relieve congestion

entertainment

Wikipedia

knowledge

23andMe had bad news about my health. I wish a person had delivered it

Telehealth for opioid use disorder is lifesaving

The high cost of giving birth even with insurance

How to make the FDA’s new prescription one

Sports medicine is finally prioritizing gender equality

Walmart eyes Medicare Advantage provider ChenMed

Hepatitis C has a cure — but many Americans still lack access to it

Physicians and social media: If you see something, say something?

Trump demands the U.S. pay no more for drugs than other countries … again

How medical schools plan to diversify without affirmative action

leisure time

Hospitals consider fixing cancer drug shortages on their own

New weight loss drugs vying to be the next Wegovy or Mounjaro

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

Future doctors should be trained to promote social change

Nurses recount patients attacks

Creating egg and sperm cells from stem cells raises ethical issues

Wikipedia

Wikipedia

Wikipedia

Wikipedia